Unicordis Pharma India Private Limited
About Unicordis Pharma India Private Limited
Data last updated:
Unicordis Pharma India Private Limited was a private limited company based in Salem, Tamil Nadu, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 April 2013.
The company was registered with the Registrar of Companies (ROC), Coimbatore, under CIN U51909TZ2013PTC019418. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8 Lakh. It was led by directors Kuppuswamy Manivannan and Karuppusamy Mohankumar.
Its last annual general meeting (AGM) was held on 30 September 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office was at 2/231/14 Alagapuram Pudur, Salem, Tamil Nadu, India – 636016.
As per the financials filed for FY 2016, the company reported a revenue of ₹17.34 Lakh, a decline of 2% compared to the previous year. For the same year it recorded a net loss of ₹7.36 Lakh (net margin -42.5%) and EBITDA of -₹6.93 Lakh (EBITDA margin -40%).
Company details
Contact details
Unicordis Pharma India Private Limited's registered office is in Salem, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address2/231/14 Alagapuram Pudur, Salem, Tamil Nadu, India – 636016
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Unicordis Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Unicordis Pharma India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Unicordis Pharma India Private Limited, buy the company report.
Financials of Unicordis Pharma India Private Limited
FY 2016 filings availableUnicordis Pharma India Private Limited reported revenue of ₹17.34 Lakh (down 2% YoY) for FY 2016.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹17.34 Lakh | |
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹6.93 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹7.36 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -40% | |
| Net Profit Margin | -42.5% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Unicordis Pharma India Private Limited, buy the company report.
Board of directors of Unicordis Pharma India Private Limited
Unicordis Pharma India has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Karuppusamy Mohankumar | Additional Director | 18 Nov 2017 | 8 Years 11 Months | As last reported |
| Kuppuswamy Manivannan | Director | 23 Apr 2013 | 13 Years 6 Months | As last reported |
Peer comparison
Unicordis Pharma India Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Raare Medpro Private Limited | ₹17.37 Lakh (FY 2025) | -26.0% | Kolkata, West Bengal, India | |||
| BK and BS Enterprises Private Limited | ₹17.34 Lakh (FY 2024) | -48.0% | Hyderabad, Telangana, India | |||
| Unicordis Pharma India Private Limitedthis company | ₹17.34 Lakh (FY 2016) | -₹7.36 Lakh | -42.5% | -2.0% | Salem, Tamil Nadu, India | |
| Shashank Medi Pharma Private Limited | ₹17.33 Lakh (FY 2020) | -55.0% | Lucknow, Uttar Pradesh, India | |||
| Natchura Pharma Limited | ₹17.29 Lakh (FY 2025) | 13.0% | Salem, Tamil Nadu, India | |||
| Sumanasham Pharma Private Limited | ₹17.27 Lakh (FY 2024) | 72.0% | Badangpet, Telangana, India | |||
| Biospace Medical System Private Limited | ₹17.25 Lakh (FY 2019) | -46.0% | Patna, Bihar, India |
To see the full peer comparison of Unicordis Pharma India Private Limited, buy the company report.
Auditor
Unicordis Pharma India Private Limited is audited by PALRAJ & SENTHIL for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PALRAJ & SENTHIL | FY 2016 | 007013S |
Shareholding
The shareholding of Unicordis Pharma India Private Limited is on record for FY 2016, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2016 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Unicordis Pharma India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Unicordis Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unicordis Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Unicordis Pharma India has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Unicordis Pharma India Private Limited, buy the company report.
Recent activity
Unicordis Pharma India Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Arjunan Manimarane ceased to be Director on 31 Aug 2018.
Frequently asked questions
Unicordis Pharma India has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Unicordis Pharma India was a private limited company based in Salem, Tamil Nadu, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 April 2013 and is registered under CIN U51909TZ2013PTC019418. The company has been struck off by the Registrar of Companies and is no longer operational.
Unicordis Pharma India had 2 directors:
- Karuppusamy Mohankumar - Additional Director
- Kuppuswamy Manivannan - Director
The CIN (Corporate Identification Number) of Unicordis Pharma India is U51909TZ2013PTC019418. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Unicordis Pharma India is at 223114 Alagapuram Pudur, Salem, Tamil Nadu, India – 636016.
Unicordis Pharma India was incorporated on 23 April 2013. It is registered with the Registrar of Companies, Coimbatore.
The latest financial statements of Unicordis Pharma India on record with the MCA are for the year ended 31 March 2016. Its last annual general meeting was held on 30 September 2016. Year-wise statements from 2015 are in the company report.
No. Unicordis Pharma India has 1 GST registration on record and it is cancelled or inactive.
Unicordis Pharma India operated in the pharma industry, in the pharmaceutical retailers and distributors segment. It worked in this industry before it was struck off.
The peers of Unicordis Pharma India by revenue are Raare Medpro Private Limited, BK and BS Enterprises Private Limited, Shashank Medi Pharma Private Limited, Natchura Pharma Limited, Sumanasham Pharma Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Arjunan Manimarane ceased to be Director on 31 Aug 2018. Karuppusamy Mohankumar was appointed as Additional Director on 18 Nov 2017. Kuppuswamy Manivannan was appointed as Director on 23 Apr 2013.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
